Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-006702
Filing Date
2025-01-28
Accepted
2025-01-28 16:15:16
Documents
2
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm254601-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm254601-1_3seq1.xml 3 1607
2 EXHIBIT 24.1 tm254601d1_ex24-1.htm EX-24.1 8370
  Complete submission text file 0001104659-25-006702.txt   11628
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07940
Business Address
Lee Joyce J. (Reporting) CIK: 0001567830 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36410 | Film No.: 25564351